European Focus in Myeloproliferative Neoplasms and Myelodysplastic Syndromes 2017

Submitted by onc_editor on Mon, 01/22/2018 - 15:34

Key Insights

European Focus in Myeloproliferative Neoplasms and Myelodysplastic Syndromes 2017

Ongoing discoveries continue to lead to preclinical breakthroughs and clinical advances in how MPN and MDS are diagnosed and treated. This was the focus of European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, held April 21-23, 2017 in Prague. In this activity, the Congress co-chairs highlight the key points presented during the meeting, with the aim of sharing updates that will help you enhance your clinical practice.